Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21,087 | 27,487 | 35,029 | 40,939 | 46,690 |
| TOTAL | $21,325 | $27,823 | $35,528 | $41,626 | $47,508 |
| Non-Current Assets | |||||
| PPE Net | 675 | 727 | 746 | 719 | 661 |
| Other Non-Current Assets | 459 | 454 | 453 | 456 | 352 |
| TOTAL | $1,133 | $1,181 | $1,199 | $1,176 | $1,013 |
| Total Assets | $22,458 | $29,004 | $36,727 | $42,801 | $48,521 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,900 | 2,648 | 2,909 | 1,638 | 1,489 |
| Accrued Expenses | 4,281 | 4,083 | 3,397 | 3,432 | 2,335 |
| TOTAL | $6,182 | $6,731 | $6,306 | $5,070 | $3,824 |
| Non-Current Liabilities | |||||
| TOTAL | $60 | $59 | $51 | $36 | $44 |
| Total Liabilities | $6,242 | $6,790 | $6,357 | $5,106 | $3,867 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 143 | 143 | 142 | 142 | 141 |
| Common Shares | 21 | 21 | 21 | 21 | 21 |
| Retained earnings | -74,953 | -68,453 | -59,829 | -52,131 | -44,807 |
| TOTAL | $16,217 | $22,214 | $30,370 | $37,695 | $44,654 |
| Total Liabilities And Equity | $22,458 | $29,004 | $36,727 | $42,801 | $48,521 |